EFFECT OF A SYNTHESIS PRODUCT (BY-PRODUCT OF SALICYLIC ACID) IN COMPARISON WITH BASIS STRUCTURAL COMPOUNDS ON SOME PROTEIC METABOLISM PARAMETERS IN RATS by LETIłIA STANA et al.
  798
Lucrări  tiinŃifice Zootehnie  i Biotehnologii, vol. 41 (1) (2008), Timi oara 
 
EFFECT OF A SYNTHESIS PRODUCT (BY-PRODUCT OF 
SALICYLIC ACID) IN COMPARISON WITH  BASIS 
STRUCTURAL COMPOUNDS ON SOME  PROTEIC 
METABOLISM PARAMETERS IN RATS 
 
EFECTUL ADMINISTRĂRII UNUI PRODUS DE SINTEZĂ 
(DERIVAT AL ACIDULUI SALICILIC), COMPARATIV CU 
COMPONENłII STRUCTURALI DE BAZĂ, ASUPRA UNOR 
PARAMETRI AI METABOLISMULUI  PROTEIC LA 
 OBOLANI 
 
STANA LETIłIA*, TRIF ALEXANDRA*, STANA LOREDANA 
GABRIELA**, LUPEA ALFA XENIA***, PĂDURE MIRABELA***, 
MUSELIN F.* 
 
*Faculty of Veterinary Medicine Timişoara, Romania,  
** University of Medicine and Pharmacy, Timişoara, RomaniIa, 
*** Industrial Chemistry and Environmental Engineering Faculty, Timişoara, Romania 
 
The aim of the study was to relieve the effect of synthesis product (by-product of 
salicylic  acid)  administration  5-cloro-2hidroxy-azotil-sulfamoil-fenil  benzamide 
(5ClSA-SA)  in  comparison  with  basic  structural  compounds  (salicylamide  and 
sulfanilamide)  on  some  parameters  of  proteic  metabolism  on  rats.  The  synthesis 
product 5ClSA-SA is amide of 5 chlorosalycilic acid with sulfanilamide synthesized 
at  The  Technical  University,  Faculty  of  Industrial  Chemistry  of  Timisoara.  The 
experimental results demonstrate that the synthesis product has determinate a strong 
significant increase (p<0.01) of proteinemia compared to test, over the physiological 
limits; salicylamide has induces the significant increase (p<0.05), and sulfanilamide 
has induced the significant decrease (p<0.05) of total proteins compared to test but 
in physiological limits. After the administration of the three substances, the albumin 
and urea values has strong significant decrease (p<0.01) compared to test and under 
the  physiological  limits.  The  synthesis  product  has  not  determinate  significant 
differences (p>0.05) of creatinine compared to test, obtained values being situated in 
physiological  limits,  while  salicylamide  and  sulfanilamide  have  induced  strong 
significant decrease (p>0.01), respectively significant (p>0.05) compared to test and 
under physiological limits. 
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Introduction 
 
The present paper study the in vivo effect of 5ClSA-SA synthesis product 
(5ClSA-SA  -  amide  of  5  chlorosalycilic  acid  with  sulfanilamide,  product   799
synthesized  at  The  Technical  University,  Faculty  of  Industrial  Chemistry  of 
Timisoara .[2,3,6]) over some protein metabolism parameters in comparison with 
basic structural compounds of this substance in perspective of therapeutically use. 
 
Materials and Methods 
 
The study was done on 35 Wistar white rats, in five groups: 2 test groups C1 
and C2 and three experimental groups E1, E2 and E3. The synthesis product (5ClSA-
SA), salicylamide (SA) and sulfanilamide (SU) was intraperitoneally administrated 
for 7 consecutive days to the experimental groups as follow: E1 – 0.44 mg 5ClSA-
SA/kg m.c.; E2 – 0.185 mg SA/kg m.c.; E3 – 0.23 mg SU/kg m.c. 
The 5 ClSA-SA administrated dozes had 1/10 DL50 salycilamide constituent, 
salycilamide was administrated in dose of 1/10 DL50 and the sulfanilamide was 
administrated in  dozes equal to the  ones contained  in  5ClSA-SA  administrated 
dose. To the C2 group was administrated the same quantities of distilled water (0.3 
ml). 
Blood was sampling at zero moment from C1 group, and at 24 h since the 
seventh administration from E1, E2, E3 and C2 groups. Was determinate the total 
protein, albumin, urea and creatinine values with VET SCREEN tester. 
 
Results and Discussions  
 
The results are presented in table 1 and 2. 
Table 1 
Average values of total protein (g/dL) and albumin (mg/dL) on experimental and 
test groups 
 
Group  Protein 
Sx x±  
D.S.  Confidence 
level 
 95% 
Albumin 
Sx x±  
D.S  Confidence 
level 
 95% 
C1  7.41  ± 0.08  0.24  0.19  4.01 ± 0.02  0.17  0.12 
C2  7.50  ± 0.10  0.25  0.19  3.99 ± 0.06  0.16  0.12 
E1  8.23 ± 0.14*  0.37  0.19  2.66 ±0.09*  0.24  0.12 
E2  7.79 ± 0.03**  0.09  0.19  2.90 ±0.05*  0.14  0.12 
E3  7.04 ± 0.13*  0.35  0.19  2.71 ±0.05*  0.13  0.12 
*p<0.01 
**p<0.05 
 
Proteinemia on E1 and E2 groups has strong significant increase (p<0.01) and 
respectively significant (p<0.05), (E1/C2: + 9.73%; E2/C2 :+ 3.89%), and on E3 
group  has  significant  decrease(p<0.05),  (E3/C2:  -  6.13%)  compared  to  test,  in 
physiological limits on SA and SU groups [8] on administration of with 5ClSA-SA 
product.   800
Table 2 
Average values of urea (mg/dL) and creatinine (mg/dL) on experimental and test 
groups 
 
Group  Urea 
Sx x±  
D.S.  Confidence 
level 
 95% 
Creatinine 
Sx x±  
D.S.  Confidence 
level 
 95% 
C1  39.88 ± 0.05  1.55  1.25  0.62 ± 0.03  0.09  0.07 
C2  40.14 ± 0.59  1.57  1.25  0.63 ± 0.04  0.10  0.07 
E1  26.29 ±0.52*  1.38  1.25  0.6 ± 0.03 
ns  0.08  0.07 
E2  29.57 ±0.75*  1.99  1.25  0.47 ±0.03*  0.08  0.07 
E3  26.86±0.40*  1.07  1.25  0.51±0.03**  0.09  0.07 
E1/C2
ns – insignifican,*p<0.01, **p<0.05 
 
The  proteic  metabolism  exploration  is  useful  especially  in  inflammatory, 
genetic and nutrition diseases and others [4]. Experimental studies with aspirin and 
others silicates revealed that this substance has many pharmacological actions, but 
it neither is nor clear if their actions are bounded to cell proteins [9]. Xenobiotics 
metabolisation can cause injury of hepatocytes with perturbation of cell function 
and form of reactive species of oxygen. Some by-products of salicylic acid can 
have baneful effects on liver [4]. Oxidative stress is one of the main mechanisms of 
chemical  hepatotoxicity  [1].  On  rodents,  in  inflammatory  processes  were 
demonstrated the high produce of nitric oxide (NO) by INOX (induced synthetasys 
nitroxyd) from hepatocytes. Billiard and co. (1995) quoted by Dejica [1] has “in 
vitro” demonstrated on hepatocyte cultures that NO inhibit the proteic synthesis. 
This result is in contradiction with Frederich and co (1993) quoted by Dejica [1] 
that  revealed  “in  vivo”  capacity  of  NO  to  over-adjust  the  proteic  synthesis  in 
endotoxemy.  
The  albumin  registered  strong  significant  decreases  (*p<0.01)  in  all 
experimental  groups  compared  to  test  (E1/C2:-33.3%;  E2/C2:-27.31%;  E3/C2  :-
32.08%) and under the physiological limits [8]. In the inflammatory system are 
registered decreases of albumin fractions. Serum albumin concentration decrease is 
produced  in  affections  that  lead  to  hepatic  parenchyma  damage  because  her 
synthesis  is  realized  at  hepatic  level  [4].  Hepatic  parenchyma  damage  was 
accentuated  also  through  AST  and  ALP  transaminases  determination  in  equal 
experimental conditions, consecutively to 5ClSA-SA, SA and SU administration 
[7]. In all the experimental groups, urea registered a strong significant decrease 
(p<0.01)  compared to  test  (E1/C2:  -34.5%;  E2/C2:  -33.8%;  E3/C2:  -33.08%)  and 
under the physiological limits [5]. Urea determination is a way to appreciate the 
level  of  renal  parenchyma  affectation  [4].  On  5ClSA-SA  administration,  the 
average values of creatinine was not significant (p>0.05) changed compared to test 
[8],  but  SA  and  SU  administration  has  determinate  strong  significant  decrease   801
(p<0.01)  respectively  significant  (p<0.05)  compared  to  test,  but  the  creatinine 
values was situated in physiological limits [8]. 
 
Conclusions 
 
·  The administration of 5ClSA-SA synthesis product determinate the 
increase  of  proteinemia  over  the  physiological  limits,  while  its  basic 
structural  compounds,  SA  and  SU,  induced  proteinemia  variations  in 
physiological limits. 
·  Albumin and urea had registered significant decrease compared to 
test and to physiological limits consecutively to administration of the three 
used substances. 
·  Creatinine values has strong significant decrease compared to test 
but in physiological limits on SA and SU administration, and insignificant on 
5ClSA-SA administration.  
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